Sebastian Krawiec

Democratic Senators Ron Wyden and Jeff Merkley are urging FDA Commissioner Scott Gottlieb to update regulations for food, beverage, and dietary supplement products that contain hemp-derived CBD. 

Using an in vivo obesity model with mice, researchers from DuPont Nutrition & Health in conjunction with the University of Eastern Finland were able to demonstrate that betaine enhanced metabolism in adipose tissue and reduced inflammation from a high-fat diet. 

Nuritas and Pharmavite LLC have entered into a discovery and option agreement. 

Ancient Nutrition welcomes new CEO, Greg Shearson

Archer Daniels Midland Company has reached an agreement to acquire Florida Chemical Company, a division of Flotek Industries. 

Some notable predictions include aronia as the next high-profile superfruit, renewed interest in mitochondrial health, and new dosage forms for sleep-support products. 

Critics say that USDA's mandatory GMO labeling standards are insufficient. 

Twinlab Consolidated Holdings Inc. has announced that it will be hosting a bi-monthly video podcast called “The Science of CBD” 

The first patient has been enrolled in a clinical study assessing the safety and tolerability of a nutritional formula that contains exogeneous ketones for use in dietary interventions for those with Angelman syndrome. 

A recently published review of weight-loss strategies and supplements found that chromium picolinate most effectively maintained lean body mass in subjects compared to other weight-loss strategies.

Probiotics may be an effective adjuvant therapy to antibiotics for the treatment of bacterial vaginosis, says new clinical trial. 

Gold Coast Ingredients has announced that its new S.M.A.R.T. Center, located in Santa Fe Springs, CA, is now open. 

A proposal under consideration by the Arizona Board of Pharmacy that would have severely limited dietary supplement access and commerce in the state has been reconsidered. 

Designs for Health, a practitioner channel dietary supplement company, has launched Annatto-E, a line of vitamin E tocotrienols derived from the South American annatto plant (Bixa orellana).  

Sabinsa Corp. has opened an office in the greater Toronto area, further expanding its already significant presence in the Canadian market.

Ingredion has announced a combined $140 million in strategic investments to accelerate the company’s production of plant proteins globally.

Fresh snacks, those that require refrigeration, exude a sense of healthfulness that shelf-stable snacks often do not.

TruNiagen expands to Canadian market and launches new delivery format to reach wider consumer base. 

New research shows that S-adenosyl-L-methionine (SAMe) combined with a vitamin B complex may improve mild and moderate depressive symptoms.

Lonza (Greenwood, SC) has been granted U.S. Patent 10,016,382 for its L-carnitine’s use in pet food to support performance and recovery in active dogs.

The signing of a Memorandum of Understanding between Sami-Sabinsa Group and the Japan External Trade Organization sets the stage for Sabinsa's continued expansion in Japan.  

Researchers have discovered two novel anti-inflammatory compounds that are converted from eicosatetraenoic acid (ETA), a long-chain omega-3 fatty acid elevated by the consumption of Ahiflower oil.

New study finds that probiotics reduced inflammation in athletes.

New research finds that krill oil may significantly reduce fasting blood glucose. 

Sabinsa's branded black cumin seed extract showed significant anti-inflammatory ability on asthma-related mediators of inflammation.

The Agriculture Improvement Act of 2018 is poised to be signed into law by President Trump after passing the House of Representatives on December 10 and the Senate on December 11. 

Two unpublished clinical studies have tested the bioequivalence of vitamin C and vitamin D gummies from Vitafusion compared to traditional tablets. 

The companies have entered into a binding letter of intent that a portion of Radient Technologies’ health and wellness solutions business will be folded into the joint venture along with a portion of Grupo Natac’s existing business in order to form Natac Solutions.

Three years after becoming a majority shareholder in Gnosis, Lesaffre has fully acquired the Italian biotechnology company.